Upside:
$DXYZ 30% (strength after report SpaceX to potentially file for IPO as early as this week)
$BRZE 20% (momentum)
$ELVN 18% (strength following Merck announcement to acquire Terns in $6.7B deal)
$QNRX 16% (FDA indicated that a single Phase 3 study may be sufficient to support marketing approval in the U.S. after Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome)
$ARM 12% (guidance from investor event)
$DNLI 11% (receives US FDA BLA Type 1 approval for Avlayah)
$NOTE 11% (launches PolicyNote MCP in OpenAI app store)
$CHWY 7.9% (earnings, guidance)
$TERN 5.6% (Merck confirms to acquire Terns, including lead asset TERN-701, for $53/shr)
$PDD 4.5% (earnings, color)
$ONDS 4.4% (earnings, guidance)
$BEAM 4.2% (announces updated clinical data from ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to support advancement to Pivotal Development)
$JD 3.8% (recent notable strength being attributed to China authorities stepped up efforts to end the intense competition in the food-delivery sector that has driven down profits)
$HOOD 3.5% (Board authorizes $1.5B common share repurchase program)
$BABA 3.4% (recent notable strength being attributed to China authorities stepped up efforts to end the intense competition in the food-delivery sector that has driven down profits)
$SRPT 3.4% (early clinical results of αvβ6 integrin-targeted siRNA approach achieves high muscle concentrations without dose limiting toxicity for facioscapulohumeral muscular dystrophy type 1 (FSHD1) and myotonic dystrophy type 1 (DM1))
$PAYX 3.3% (earnings, guidance)
Downside:
$AVXL -31% (withdraws application for marketing authorization of blarcamesine in EU as an add-on therapy for treatment of early Alzheimer’s disease in adults, which had been under review by European Medicines Agency (EMA))
$ARTL -16% (issues glaucoma study update)
$ABSI -8.6% (earnings)
$DOCN -7.9% (prices upsized common stock offering)
$LBRT -6.4% (files to sell $450M in convertible notes due 2032 with up to $50M option)
$FPS -5.1% (Holders to offer 20.6M shares and announces offering of 9.3M shares)
$ONON -5.1% (announces leadership change and share conversion)
$KBH -3.1% (earnings, guidance)